1A. Manto,P. Cotroneo,G. Porcelli,G. D’Errico,G. Marra,P. Magnani,P. Tilli,A. V. Greco,G. Ghirlanda. Urinary kallikrein excretion in Type 1 (insulin-dependent) diabetes mellitus[J] 1993,Diabetologia(5):423～427
2Dr. J. N. Harvey,A. W. Edmundson,A. A. Jaffa,L. L. Martin,R. K. Mayfield. Renal excretion of kallikrein and eicosanoids in patients with Type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function[J] 1992,Diabetologia(9):857～862
3Dr. T. Baba,S. Murabayashi,T. Ishizaki,Y. Idol,K. Aoyagi,K. Takebe. Renal kallikrein in diabetic patients with hypertension accompanied by nephropathy[J] 1986,Diabetologia(3):162～167
5Ravid M,Lang R,rachmani R,et al.Long-lem renoprotective effect of angotensin-conveting enzyme inhibition in non-imsulin-depondtent diabetes mellitus A 7-year follow-up studw.Ach in Tem Med,1996,56:286-289.
6Miyazaki M.Circulatory effect of kallikrein with special reference to cerebral circulation advances in experimental.Medicine and Biology,1989,247:607-610.
7[1]U K Prospective Diabetes Study Group.UK Prospective Diabetes Study 16:Overview of 6 years' therapy of type Ⅱ diabetes:A Progressive diabetes[J].Diabetes,1995,44:1 249～1 258.
8[2]Revid M.Long-term venoprotective effect of angiotensin-converting enzyme inbibition in non-insolindependent diabetes metitus:A 7-year follow-up study[J].Arch Intern Med,1996,156:286.
9[4]Miyazazaki M.Circulatory effect of kallikrein:with special reference to cerebral circulation[J].Advances in Experimental Medicine and Biolgy,1989,247(B):607.
